Multiple endocrine neoplasia type 1 (MEN1), a rare tumor syndrome that is inherited in an
autosomal dominant pattern, is continuing to raise great interest for endocrinology …

Multiple endocrine neoplasia type 1 (MEN1) is a rare syndrome characterized by the co-
occurrence of primary hyperparathyroidism, duodenopancreatic neuroendocrine tumours …

Only advances that occurred from 2011 to 2014 that either strengthen the previous 2011
guidelines [1, 2] or lead to changes or additional guidelines are reviewed here. Advances …

Multiple endocrine neoplasia type 1 (MEN1) is a rare hereditary tumor syndrome inherited in
an autosomal dominant manner and characterized by a predisposition to a multitude of …

Neuroendocrine neoplasms (NENs) are rare neoplasms that occur in various organs and
present with diverse clinical manifestations. Pathological classification is important in the …

Abstract Background Although neuroendocrine tumors (NETs) are rare, the number of
patients with NET is increasing. However, in Japan, there have been no epidemiological …

The better understanding of the biological behavior of multiple endocrine neoplasia type 1
(MEN1) organ manifestations and the increase in clinical experience warrant a revision of …

The androgen receptor (AR) signaling axis drives all stages of prostate cancer, including the
lethal, drug-resistant form of the disease termed castration-resistant prostate cancer (CRPC) …

This review provides an overview of novel insights in the clinical management of patients
with Multiple Endocrine Neoplasia Type 1, focusing on the last decade since the last update …

Abstract Background Multiple Endocrine Neoplasia type 1 (MEN1) is diagnosed when two
out of the three primary MEN1-associated endocrine tumors occur in a patient. Up to 10 …